KR800001357B1 - Process for the preparation of n-(2-substitute-ethyl-1)-3-benzoyl propion amide - Google Patents
Process for the preparation of n-(2-substitute-ethyl-1)-3-benzoyl propion amide Download PDFInfo
- Publication number
- KR800001357B1 KR800001357B1 KR7603061A KR760003061A KR800001357B1 KR 800001357 B1 KR800001357 B1 KR 800001357B1 KR 7603061 A KR7603061 A KR 7603061A KR 760003061 A KR760003061 A KR 760003061A KR 800001357 B1 KR800001357 B1 KR 800001357B1
- Authority
- KR
- South Korea
- Prior art keywords
- ethyl
- benzoyl
- mol
- chloroform
- benzoy1
- Prior art date
Links
Abstract
Description
본 발명은 다음 일반식(I)로 표시된 신규한 N-(2-치환-에틸-1)-3-벤조일 프로피온아마이드의 제조방법에 관한 것이다.The present invention relates to a process for the preparation of the novel N- (2-substituted-ethyl-1) -3-benzoyl propionamide represented by the following general formula (I).
단, 식중 R은 수소원자, 할로겐 혹은 저급 알킬기를 나타내며, X는 산소원자, 유황원자 혹은R1(여기서 R1은 저급 알킬기임)를 나타낸다.]Wherein R represents a hydrogen atom, a halogen or a lower alkyl group, and X represents an oxygen atom, a sulfur atom or R 1 , where R 1 is a lower alkyl group.]
본 발명에 의해서 얻어진 N-(2-치환에틸-1)-3-벤조일 프로피온아마이드(I)은 콜레스테롤 저하 작용을 가지는 매우 유효한 의료물질이다. 그의 상세한 것은 다음에 설명한다.N- (2-substituted ethyl-1) -3-benzoyl propionamide (I) obtained by the present invention is a very effective medical substance having cholesterol lowering action. Details thereof will be described later.
본 발명의 화합물(I)을, 예를들면 다음의 방법으로 제조할 수 있다. 환언하면, 일반식(II)Compound (I) of the present invention can be produced, for example, by the following method. In other words, general formula (II)
(식 중 R 및 X는 상기한 바와 동일한 의미를 가진다)(Wherein R and X have the same meaning as described above)
로 표시되는 화합물을, 벤조일 프로피온산과 클로로 탄화 에틸로부터 생성하는 혼합산 무수물(混合酸無水物)과 반응시킴으로써 일반식(I)의 화합물이 얻어진다.The compound represented by the general formula (I) is obtained by reacting the compound represented by the mixture with an acid anhydride produced from benzoyl propionic acid and ethyl chlorocarbon.
상기의 방법에서 이용된 원료의 β-치환-에틸아민(II)의 조정은 다음과 같다. 즉 β-펜옥시에틸아민의 경우, 시판되는 β-브로모에틸-페닐 에테르를 탄산 칼륨의 존재하 프탈이미드와 가열 반응시킴으로써 수율이 좋게 얻어지며, β-페닐티오 에틸 아민의 경우는, 4염화 탄소 중 에틸렌 이민과 티오페놀을 반응시킴으로써 정량적으로 수득된다. 또한 β-N-메틸아닐리노 에틸 아민의 경우는, N-메틸 아닐린과 β-브로모에틸아민의 브록산염을 에탄올 중에서 반응시킴으로써 수득된다.The adjustment of β-substituted-ethylamine (II) of the raw materials used in the above method is as follows. That is, in the case of β-phenoxyethylamine, a good yield is obtained by heating a commercially available β-bromoethyl-phenyl ether with phthalimide in the presence of potassium carbonate, and in the case of β-phenylthioethyl amine, 4 Obtained quantitatively by reacting ethylene imine with thiophenol in carbon chloride. In the case of β-N-methylanilino ethyl amine, it is obtained by reacting N-methyl aniline with a bromate of β-bromoethylamine in ethanol.
이와 같이 하여 수득된 β-치환 에틸아민은 벤조일 프로피온산과 클로로 탄산 에틸로부터 생성되는 혼합산 무수물()과 클로로포름 중에서 반응시킴으로써 일반식(I)로 표시되는 목적 화합물로 유도할 수 있다.The β-substituted ethylamine obtained in this way is a mixed acid anhydride produced from benzoyl propionic acid and ethyl chlorocarbonate ( ) And the chloroform to be reacted with the target compound represented by the general formula (I).
본 반응의 일반적인 경로를 도시하면 하기와 같다.The general route of this reaction is shown below.
(식중 R 및 X는 상술한 바와 같은 의미를 가진다)(Wherein R and X have the same meaning as described above)
다음에 본 발명 화합물과 각각의 융점을 나타낸다.Next, the melting points of the compounds of the present invention are shown.
이들 신규 유도체는 콜레스테롤 저하 작용을 가지는 극히 유효한 의료 물질이며, 이하에 그의 약리 시험의 방법 및 결과를 나타낸다.These novel derivatives are extremely effective medical substances having a cholesterol lowering action, and the methods and results of their pharmacological tests are shown below.
가) 혈청 콜레스테롤 저하 작용A) Serum Cholesterol Lowering Action
위스타계 웅성 래트(체중 180-220g, 1군에 5-10마리)를 이용하여 트리톤(Triton) WR-1339의 300mg/kg를 꼬리 정맥으로 투여하고, 18시간 후에 채혈하여 혈청 총 콜레스테롤 값을 자크-헨리(Zak-Henly) 변법에 의해, 비색 정량하였다. 한편 검체는 0.2% 한천 함유 생리 식염수에 현탁시키어, 100mg/kg을 복강 내에 트리톤과 동시에 투여하였다.Using 300 mg / kg of Triton WR-1339 into the tail vein using Wistar male rats (180-220 g in weight, 5-10 in group 1), 18 hours later, blood was collected and zac Colorimetric quantification was performed by the Zak-Henly variant. The sample was suspended in physiological saline containing 0.2% agar, and 100 mg / kg was administered simultaneously with Triton intraperitoneally.
나) 지방 세포로부터의 유리 지방산 방출 억제 작용B) inhibition of free fatty acid release from fat cells
로드벨(Rod bell)의 방법에 의해서 조정한 래트 지방 세포를 검체 10-4M, 놀에피네프린(Norepinephrine) 4×10-6M, 및 알부민 3%를 함유한 KRB(Krebs 중탄산 완충액) 중에서 30분 인큐배이트 하여 방출된 유리 지방산을 이타야 위(Itaya, Ui)의 방법으로 비색 정량하였다.Rat fat cells adjusted by the method of Rod bell were 30 minutes in a sample 10 −4 M, Norepinephrine 4 × 10 −6 M, and KRB (Krebs bicarbonate buffer) containing albumin 3%. Free fatty acids released by incubation were colorimetrically quantified by the method of Itaya (Ui).
이하에 실시예를 나타낸다. 실시예의 번호는 화합물 번호와 대응되며, 또한 융점은 일람표 중에 있으며 이하에서는 생략한다.An example is shown below. The numbers in the examples correspond to the compound numbers, and the melting points are in the list and are omitted below.
[실시예 1]Example 1
N-[2-(N-에틸아닐린) 에틸]-3-벤조일프로피온 아미드N- [2- (N-ethylaniline) ethyl] -3-benzoylpropion amide
15ml의 클로로포름에 17.8g(0.1몰)의 3-벤조일프로피온산 및 10.1g(0.1몰)의 트리에틸아민을 용해하고, 냉각, 각반하, 1시간에 걸쳐 30ml의 클로로포름에 용해시킨 클로르탄산 에틸 10.85g(0.1몰)의 용액을 가한다. 더우기 반응액을 3시간 교반한다. 계속하여, 0.1몰(15.0g)의 2-(N-메틸 아닐리노) 에틸아민을 50ml의 클로로포름에 용해시킨 용액을, 교반하, 15분간 적가하고, 더우기 반응 혼합물을 17시간 교반한다. 이어서, 반응 혼합물을 수세하고, 클로로포름층을 황산 마그네슘으로 건조, 감압하 농축하면 오일상 잔사를 얻는다. 에테르/헥산을 그의 오일에 소량 가하여 결정화시키고 초산 에틸/헥산(2/1)로 재결정하여 25g의 목적물을 얻는다.10.85 g of ethyl chlorate dissolved in 15 ml of chloroform in 17.8 g (0.1 mole) of 3-benzoylpropionic acid and 10.1 g (0.1 mole) of triethylamine, and dissolved in 30 ml of chloroform over 1 hour under cooling, angular stripping. (0.1 mol) of solution is added. Furthermore, the reaction solution is stirred for 3 hours. Subsequently, a solution obtained by dissolving 0.1 mol (15.0 g) of 2- (N-methyl anilino) ethylamine in 50 ml of chloroform is added dropwise while stirring, and further, the reaction mixture is stirred for 17 hours. The reaction mixture is then washed with water, the chloroform layer is dried over magnesium sulfate and concentrated under reduced pressure to give an oily residue. A small amount of ether / hexane is added to its oil to crystallize and recrystallized from ethyl acetate / hexane (2/1) to obtain 25 g of the desired product.
원소 분석치(%)Elemental Analysis Value (%)
계산치 : C : 73.52 H : 7.14 N : 9.03Calculated Value: C: 73.52 H: 7.14 N: 9.03
실측치 : C : 73.15 H : 7.28 N : 8.95Found: C: 73.15 H: 7.28 N: 8.95
[실시예 2]Example 2
N-[2-(N-메틸-P-클로로아닐리노) 에틸]-3-벤조일프로피온아미드N- [2- (N-methyl-P-chloroanilino) ethyl] -3-benzoylpropionamide
실시예 1과 동일하게 조작하여, 클로로 탄산 에틸 10.85g(0.1몰), 3-벤조일프로피온산 17.82g(0.1몰), 트리에틸 아민 10.1g(0.1몰), 2-(N-메틸-P-클로로아닐리노)-에틸아민 18.2g(0.1 몰)를 클로로포름 중에서 반응시킴으로써 목적물을 얻는다. 수량 27g.In the same manner as in Example 1, 10.85 g (0.1 mol) of ethyl chloro carbonate, 17.82 g (0.1 mol) of 3-benzoylpropionic acid, 10.1 g (0.1 mol) of triethyl amine, and 2- (N-methyl-P-chloro 18.2 g (0.1 mol) of anilino) -ethylamines are reacted in chloroform to obtain the desired product. Quantity 27g.
원소분석치(%)Elemental Analysis Value (%)
계산치 C : 66.17 H : 6.13 N : 8.13Calculated Value C: 66.17 H: 6.13 N: 8.13
실측치 C : 66.17 H : 6.04 N : 8.10Found C: 66.17 H: 6.04 N: 8.10
[실시예 3]Example 3
N-[3-(N-메틸-P-브로모아닐리노) 에틸]-벤조일프로피온아미드N- [3- (N-methyl-P-bromoanilino) ethyl] -benzoylpropionamide
실시예 1과 동일하게 조작하여, 클로로 탄산 에틸 7.6g(0.07몰), 3-벤조일프로피온산 12.5g(0.07몰), 트리에틸아민 7.3g(0.07몰) 및 2-N-메틸-P-브로모아닐리노-에틸아민 16.0g(0.07몰)을 클로로포름 중에서 반응시키어 상기 표제 화합물을 얻는다. 수량 20g.In the same manner as in Example 1, 7.6 g (0.07 mol) of ethyl chloro carbonate, 12.5 g (0.07 mol) of 3-benzoylpropionic acid, 7.3 g (0.07 mol) of triethylamine, and 2-N-methyl-P-bromo 16.0 g (0.07 mol) of anilino-ethylamine are reacted in chloroform to afford the title compound. Quantity 20g.
원소분석치(%)Elemental Analysis Value (%)
계산치 C : 58.52 H : 5.44 N : 7.20Calculated C: 58.52 H: 5.44 N: 7.20
실측치 C : 58.73 H : 5.53 N : 7.10Found C: 58.73 H: 5.53 N: 7.10
[실시예 4]Example 4
N-[2-(페닐티오) 에틸]-벤조일프로피온 아미드N- [2- (phenylthio) ethyl] -benzoylpropion amide
N-메틸체의 경우와 동일하게 반응시키지만, 유황체의 경우는 반웅성이 현저히 높으므로, 반응시간이 짧은 것이 특징이다.The reaction is carried out in the same manner as in the case of N-methyl, but the reaction time is remarkably high in the case of sulfur, which is characterized by a short reaction time.
실시예 1의 경우와 동일하게, 0.1몰의 스케일로 클로르 탄산 에틸, 트리에틸아민 및 3-벤조일프로피온산을 반응시키고, 여기에 2-(페닐티오) 에틸아민 15.3g(0.1몰)의 클로로포름 용액을 가한다. 수량 29g. 벤젠으로 재결정.In the same manner as in Example 1, ethyl chlorate, triethylamine and 3-benzoylpropionic acid were reacted on a scale of 0.1 mol, and a solution of 15.3 g (0.1 mol) of 2- (phenylthio) ethylamine was added thereto. Add. Quantity 29g. Recrystallize from benzene.
원소분석치(%)Elemental Analysis Value (%)
계산치 C : 68.98 H : 6.11 N : 4.47Calculated C: 68.98 H: 6.11 N: 4.47
실측치 C : 68.70 H : 6.26 N : 4.17Found C: 68.70 H: 6.26 N: 4.17
[실시예 5]Example 5
N-[2-(P-톨릴티오) 에틸]-3-벤조일-프로피온아미드N- [2- (P-tolylthio) ethyl] -3-benzoyl-propionamide
실시예 4와 동일한 조작에 의해 0.1몰의 스케일로 조(粗)수량 33g의 목적물을 얻는다. 이것을 벤젠으로 재결정한다.By the same operation as in Example 4, a target product having a crude amount of 33 g was obtained on a scale of 0.1 mol. This is recrystallized from benzene.
원소분석치(%)Elemental Analysis Value (%)
계산치 C : 69.69 H : 6.47 N : 4.28Calculated C: 69.69 H: 6.47 N: 4.28
실측치 C : 69.58 H : 6.42 N : 4.15Found C: 69.58 H: 6.42 N: 4.15
[실시예 6]Example 6
N-[2-(P-클로르·틸 티오) 에틸]-3-벤조일 프로피온아미드N- [2- (P-chloryl thio) ethyl] -3-benzoyl propionamide
N-메틸체의 경우와 동일하게 반응시키지만, 유황체의 경우은 반응성이 현저히 높으므로 반응시간이 짧은 것이 특징이다.The reaction is carried out in the same manner as in the case of N-methyl body, but in the case of sulfur body, the reactivity is remarkably high, so the reaction time is short.
실시예 1의 경우와 동일하게 0.1몰의 스케일로 클로로탄산 에틸, 트리에틸아민 및 3-벤조일프로피온산을 반응시키고, 2-(P-클로로페닐티오) 에틸아민 18.8g(0.1몰)의 클로로포름 용액을 가하면 직접 결정이 석출한다. 이것을 여취하여, 클로로포름 층을 수세, 건조, 감압하 클로로포름을 유거하고 잔사에 결정을 얻는다. 먼저 여취한 결정과 합하여 조수량 34g의 목적물을 얻는다. 이것을 벤젠-초산 에틸로 재결정한다.In the same manner as in Example 1, ethyl chlorocarbonate, triethylamine and 3-benzoylpropionic acid were reacted on a scale of 0.1 mol, and a 18.8 g (0.1 mol) of chloroform solution of 2- (P-chlorophenylthio) ethylamine was added. When added, crystals are precipitated directly. This is filtered, the chloroform layer is washed with water, dried and the chloroform is distilled off under reduced pressure to obtain crystals in the residue. Firstly, the target product with 34g of fresh water is obtained in combination with the crystals. This is recrystallized from benzene-ethyl acetate.
원소분석치(%)Elemental Analysis Value (%)
계산치 C : 62.15 H : 5.21 N : 4.03Calculated C: 62.15 H: 5.21 N: 4.03
실측치 C : 62.11 H : 5.23 N : 3.74Found C: 62.11 H: 5.23 N: 3.74
[실시예 7]Example 7
N-[2-(P-클로로펜옥시) 에틸]-3-벤조일프로피온아미드N- [2- (P-chlorophenoxy) ethyl] -3-benzoylpropionamide
유황체의 경우와 동일하게 N-CH3체(體)보다 반응성이 높으며 후처리 방법도 유황체의 경우와 동일하게 행하였다. 0.06몰의 스케일로 조수량 20g의 목적을 얻는다.As in the case of the sulfur body, the reactivity was higher than that of the N-CH 3 body, and the post-treatment method was also performed in the same manner as in the case of the sulfur body. An objective of 20 g of fresh water is obtained on a scale of 0.06 moles.
원소분석치(%)Elemental Analysis Value (%)
계산치 C : 65.16 H : 5.47 N : 4.22Calculated C: 65.16 H: 5.47 N: 4.22
실측치 C : 65.00 H : 5.43 N : 4.16Found C: 65.00 H: 5.43 N: 4.16
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR7603061A KR800001357B1 (en) | 1976-12-11 | 1976-12-11 | Process for the preparation of n-(2-substitute-ethyl-1)-3-benzoyl propion amide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR7603061A KR800001357B1 (en) | 1976-12-11 | 1976-12-11 | Process for the preparation of n-(2-substitute-ethyl-1)-3-benzoyl propion amide |
Publications (1)
Publication Number | Publication Date |
---|---|
KR800001357B1 true KR800001357B1 (en) | 1980-11-17 |
Family
ID=19203008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR7603061A KR800001357B1 (en) | 1976-12-11 | 1976-12-11 | Process for the preparation of n-(2-substitute-ethyl-1)-3-benzoyl propion amide |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR800001357B1 (en) |
-
1976
- 1976-12-11 KR KR7603061A patent/KR800001357B1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900001509B1 (en) | (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols and its preparation | |
SU888821A3 (en) | Method of preparing 5-(substituted phehyl)-oxazolidinones or their sulphur-containing analogs | |
JP2556722B2 (en) | Novel sulfonamide compound | |
US3238224A (en) | Production of 6, 8-dithiooctanoyl amides | |
CH641154A5 (en) | SUBSTITUTED HETEROCYCLIC BENZAMIDES. | |
WO1997037982A1 (en) | Novel substituted [2-(1-piperazinyl)ethoxy]methyl | |
EP0094102B1 (en) | 1-(1-cyclohexanyl-methyl) pyrrolidine derivatives, and process for their preparation | |
CA1081696A (en) | Sulphide compounds | |
EP0348257A2 (en) | (Hetero)aryl-diazole derivatives, process for their preparation and their therapeutical use | |
KR800001357B1 (en) | Process for the preparation of n-(2-substitute-ethyl-1)-3-benzoyl propion amide | |
EP0233432B1 (en) | Polyfluoralkylthiomethyl compounds, processes for their preparation and their use as tensio-active compounds or as precursors therefor | |
CH648329A5 (en) | PROCESS FOR THE PREPARATION OF STEROIDS. | |
US4075219A (en) | Epimerization process | |
US3202712A (en) | 1-cyclohexene-4-bis (omicron-chlorobenzylaminomethyl) and derivatives | |
US3308132A (en) | 6, 8-dithiooctanoyl amides and intermediates | |
US4459415A (en) | Process for the preparation of 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetoxyacetic acid | |
JPS6126902B2 (en) | ||
JPS6321661B2 (en) | ||
JPH04182465A (en) | Production of n-methoxy-n-methylaminoalkylphthalimide | |
KR860000263B1 (en) | Process for the preparation of di-substituted nitriles from accto nitrile | |
BE554381A (en) | ||
JPH0359065B2 (en) | ||
JPS6039269B2 (en) | Acylketene-S/N-acetal compound and its production method | |
HU193853B (en) | Process for preparing dioxolo-benzisoxazole derivatives | |
HU201728B (en) | Process for producing 3-(2-halogenethylamino)-3-pentenedicarboxylic acid-dialkyl esters |